PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Nantes Université, CHU Nantes, CNRS, INSERM, l\'institut du thorax, F-44000, Nantes, France.\', \'Department of Diabetology, Metabolic Diseases & Nutrition, Toulouse University Hospital, Institute of Metabolic & Cardiovascular Diseases, UMR1297 INSERM/UPS, Toulouse University, Toulouse, France.\', \'CIC-EC 1413, Data Clinic, Nantes University Hospital, Nantes, France.\', \'Nantes Université, CHU Nantes, CNRS, INSERM, l\'institut du thorax, F-44000, Nantes, France. bertrand.cariou@univ-nantes.fr.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1007/s11892-022-01452-5
?:hasPublicationType
?:journal
  • Current diabetes reports
is ?:pmid of
?:pmid
?:pmid
  • 35171448
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.618
?:rankingScore_hIndex
  • 62
is ?:relation_isRelatedTo_publication of
?:title
  • COVID-19 and Diabetes Outcomes: Rationale for and Updates from the CORONADO Study.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all